Compare GFR & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GFR | BVS |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | Canada | United States |
| Employees | 197 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 698.6M | 804.8M |
| IPO Year | N/A | 2016 |
| Metric | GFR | BVS |
|---|---|---|
| Price | $6.22 | $11.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 160.4K | ★ 701.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $4.33 | $288.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.11 | $5.81 |
| 52 Week High | $7.02 | $12.30 |
| Indicator | GFR | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 64.35 | 66.25 |
| Support Level | $5.62 | $8.12 |
| Resistance Level | $6.24 | N/A |
| Average True Range (ATR) | 0.22 | 0.61 |
| MACD | 0.08 | 0.18 |
| Stochastic Oscillator | 96.63 | 87.58 |
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.